SNOMED CT Drug Model Use Cases
Introduction
The SNOMED CT Pharmaceutical / Biologic Product hierarchy provides a structured model for representing medicinal products at multiple levels of abstraction. This hierarchy includes concepts such as Medicinal Product (MP), Medicinal Product Form (MPF), and Clinical Drug (CD), which progressively add detail about ingredients, dose form, and strength.
For example:
A Medicinal Product (MP) represents a medicinal product defined only by its active ingredient(s), without specifying strength or dose form.
A Clinical Drug (CD) represents a medicinal product defined by ingredient, strength, and manufactured dose form, making it suitable for use in clinical workflows.
The International Release focuses on representing medicinal products in a way that is globally consistent, while national extensions may add concepts representing actual authorized products and packaging available in specific jurisdictions, including branded medicines and product packages.
Together, the International Drug Model and National Drug Extensions support a wide range of healthcare use cases including prescribing, dispensing, logistics, reimbursement, pharmacovigilance, and clinical decision support.
Administrative Use Cases
Administrative use cases support operational and financial aspects of healthcare systems such as procurement, logistics, and reporting.
UC.1 Procurement and Tendering
Healthcare organizations and national procurement agencies often purchase medicines through competitive tendering processes. In these processes, the purchasing authority defines the medication required using a generic specification, allowing suppliers to compete with their own authorized products.
The SNOMED CT drug model supports this process by separating generic drug definitions from real products available on the market. Procurement specifications can reference Clinical Drug (CD) concepts, while suppliers offer their products using Real Clinical Drug (RCD) and Real packaged Clinical Drug (RPCD) concepts defined in national extensions.
This approach ensures vendor-neutral procurement while maintaining precise definitions of the medicines being purchased.
Concept usage
CD
Defines the medication required in the tender
Product containing precisely amoxicillin 500 mg oral capsule (clinical drug)
RCD
Represents the specific product offered by suppliers
Brand X amoxicillin 500 mg capsule manufactured by Company Y
RPCD
Represents the specific packaged product offered by suppliers
Brand X amoxicillin 500 mg capsule, pack of 30 capsules, manufactured by Company Y
Example scenario:
A hospital publishes a tender for amoxicillin 500 mg capsules (CD). Multiple suppliers submit offers for their specific authorized products (RCDs).
UC.2 Stock Management and Pharmacy Logistics
Hospital pharmacies and distribution systems manage inventories of medications across warehouses, pharmacies, and clinical units. Stock management systems track package quantities, expiration dates, and product movement.
The SNOMED CT drug model supports these workflows by representing product packages using concepts such as Clinical Drug Package (CDP) and Real Clinical Drug Package (RPCD).
This allows inventory systems to track real packages while maintaining a link to the underlying clinical drug concept, and make this information available during the prescription process when necessary.
Concept usage
RPCD
Actual product package stored in inventory
BrandX amoxicillin 500 mg capsule box of 24 capsules
CDP
Generic package representation
Amoxicillin 500 mg capsule box of 24 (generic package)
CD
Aggregated reporting across packages
Product containing precisely amoxicillin 500 mg capsule
Example scenario:
A pharmacy stores boxes of 24 capsules of BrandX amoxicillin (RPCD). Inventory reporting aggregates all packages under the amoxicillin 500 mg capsule clinical drug concept.
UC.3 Financial Coverage and Reimbursement
Health insurance systems and national payers define reimbursement policies for medications based on ingredients, formulations, or specific products.
The SNOMED CT drug model enables reimbursement rules to be defined at different levels of abstraction. For example, coverage policies may apply to all products containing a given ingredient or may apply only to specific strengths or formulations.
Concept usage
MP
Ingredient-level reimbursement rules
Product containing metformin (medicinal product)
MPF
Ingredient + dose form reimbursement
Product containing metformin in oral tablet dose form
CD
Strength-specific reimbursement
Product containing precisely metformin 500 mg oral tablet
Example scenario:
An insurer reimburses all oral metformin tablets (MPF) but applies different reimbursement levels depending on tablet strength (CD).
UC. 4 Business Intelligence and Drug Utilization Reporting
Healthcare organizations and public health authorities routinely analyze medication usage data to monitor prescribing patterns, drug costs, and treatment trends, and to support business intelligence activities such as forecasting demand, planning procurement, and optimizing medication supply.
The hierarchical structure of the SNOMED CT drug model enables aggregation of medication data at different levels of granularity. Data recorded at the clinical drug level can be automatically aggregated at higher levels, such as ingredient or drug class.
Concept usage
MP
Ingredient-level reporting
Product containing insulin (medicinal product)
MPF
Ingredient + dose form analysis
Product containing insulin in injectable solution
CD
Detailed drug usage statistics
Insulin glargine 100 units/mL solution for injection
Example scenario:
A national health authority analyzes total insulin usage by aggregating prescriptions recorded at the clinical drug level.
Clinical Use Cases
Clinical use cases focus on the use of medications in patient care workflows.
UC.5 Electronic Prescribing
Electronic prescribing systems allow clinicians to select medications and send prescriptions electronically to pharmacies. These systems must represent medications with sufficient detail to ensure accurate dispensing.
SNOMED CT Clinical Drug (CD) concepts provide the appropriate level of detail for prescribing because they specify ingredient, strength, and dose form. In some cases, clinicians may prescribe a specific brand or package using Real Clinical Drug (RCD) or Real Packaged Clinical Drug (RPCD) concepts.
Concept usage
CD
Generic prescribing
Product containing precisely amoxicillin 500 mg oral capsule
RCD
Brand-specific prescribing
BrandX amoxicillin 500 mg capsule
CDP / RPCD
Prescribing by package
BrandX amoxicillin 500 mg capsule box of 24
Example scenario:
A physician prescribes amoxicillin 500 mg capsules using a clinical drug concept. The pharmacy system receives the prescription and selects the appropriate product.
UC.6 Pharmacy Dispensing
When a pharmacy receives a prescription, the pharmacist selects a product that fulfills the prescription. In many healthcare systems, pharmacists are allowed to substitute equivalent generic medicines.
The SNOMED CT drug model supports this workflow by linking Clinical Drug concepts with Real Clinical Drug concepts, enabling pharmacy systems to match prescriptions with available products.
Concept usage
CD
Prescribed drug
Product containing precisely amoxicillin 500 mg capsule
RCD
Dispensed product
BrandX amoxicillin 500 mg capsule
RPCD
Dispensed package
BrandX amoxicillin 500 mg capsule box of 24 capsules
Example scenario:
A prescription for amoxicillin 500 mg capsules is filled by dispensing a generic product from manufacturer Y.
UC.7 Medication Administration
In hospitals and other care settings, nurses administer medications to patients according to physician orders. Medication administration systems must record the exact product administered and verify that it matches the prescribed medication. Clinical decision support systems can support the administration step by checking contraindications, potential drug interactions, and dose appropriateness before the medication is given.
Closed-loop medication administration systems often use barcode scanning to identify the medication product before administration.
Concept usage
RCD
Product administered
Morphine sulfate 10 mg/mL solution for injection – BrandX
CD
Clinical equivalence
Product containing precisely morphine sulfate 10 mg/mL solution for injection
Route concepts
Administration route
Intravenous route (qualifier value)
Example scenario:
A nurse administers morphine 2 mg IV and records the administration using the details of the branded product. The decision support system validates the safety against recorded patient data.
UC.8 Adverse Drug Reaction Reporting
Pharmacovigilance systems collect reports of adverse reactions associated with medications. These systems must accurately identify the suspected drug to detect safety signals. If adverse reaction reports are generated directly from medication administration data recorded in the clinical record, the exact product administered can be captured without information loss, ensuring that the same product is reported to pharmacovigilance systems.
The SNOMED CT drug model allows adverse reactions to be recorded at different levels of specificity depending on available information.
Concept usage
RCD
Specific product causing reaction
BrandX amoxicillin 500 mg capsule
CD
Generic drug reaction reporting
Product containing precisely amoxicillin 500 mg capsule
MP
Ingredient-level safety monitoring
Product containing amoxicillin (medicinal product)
Example scenario:
A patient develops a rash after taking amoxicillin. The adverse reaction report is created with the accurate and appropriate information.
UC.9 Clinical Decision Support
Clinical decision support systems analyze medication orders and patient information to provide alerts and guidance to clinicians.
Typical decision support functions include drug–drug interaction checking, allergy alerts, and dose range validation.
Concept usage
MP
Ingredient-based CDS rules
Interaction rule for warfarin (medicinal product) with NSAIDs
MPF
Form-specific rules
Alert for insulin injectable products
CD
Dose validation
Maximum dose rule for paracetamol 500 mg tablet
Example scenario:
A CDS rule alerts the physician if a patient with a penicillin allergy is prescribed amoxicillin.
Knowledge and Secondary Use Cases
The SNOMED CT drug model also supports knowledge management, research, and secondary uses of medication data.
UC.10 Clinical Drug Knowledge Bases
Healthcare organizations and knowledge provider companies maintain drug knowledge databases containing information about drug interactions, contraindications, dosing guidance, and therapeutic indications.
The SNOMED CT drug model allows knowledge to be linked to standardized drug concepts, enabling consistent application and simple integration across clinical systems.
Concept usage
MP
Ingredient-level knowledge
Interaction between warfarin and ibuprofen
MPF
Form-specific rules
Dosing recommendations for inhaled salbutamol
CD
Strength-specific rules
Maximum daily dose for paracetamol 500 mg tablet
Example scenario:
A drug knowledge base defines an interaction between warfarin and NSAIDs, which is triggered during prescribing.
UC.11 Medication History and Patient Medication Lists
Electronic health records maintain medication lists representing drugs that a patient is currently taking or has taken previously. These lists support medication reconciliation and continuity of care.
Medication records may represent drugs at different levels depending on available information.
Concept usage
CD
Generic medication record
Metformin 500 mg oral tablet
RCD
Exact product taken
BrandX metformin 500 mg tablet
Example scenario:
A patient’s medication list includes metformin 500 mg tablets as a generic and Tylenol 500mg tablets as a branded product.
UC.12 Research and Pharmacoepidemiology
Researchers and public health authorities analyze medication data to study treatment outcomes, safety, and prescribing trends. Current medication use is also commonly used as a criterion for patient selection and eligibility in clinical studies.
The hierarchical structure of SNOMED CT drug concepts allows researchers to aggregate medication data at different levels.
Concept usage
MP
Population-level studies
Study of all statin medicinal products
MPF
Therapeutic category analysis
Analysis of oral statin tablets
CD
Specific dosage analysis
Study of atorvastatin 20 mg tablet